Search

Displaying results 5821 - 5830 of 10000 in total
  1. Drug

    AZD2315

    go.drugbank.com/drugs/DB06540
    Experimental

    The drug AZD2315, an immunosuppressant developed by AstraZeneca, was in Phase 1 clinical trials for the treatment of rheumatoid arthritis but was discontinued during this phase

  2. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  3. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  4. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  5. Drug

    LIC-477

    go.drugbank.com/drugs/DB05363
    Experimental

    LIC-477is indicated to be suitable for the treatment of psychosomatic disturbances, epilepsy, trigeminal neuralgia and cerebral spasticity.

  6. Drug

    Cantuzumab ravtansine

    go.drugbank.com/drugs/DB05594
    Investigational

  7. Drug

    Glypromate

    go.drugbank.com/drugs/DB05633
    Experimental

    Neuren Pharmaceuticals was developing Glypromate (glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for the potential treatment of neurodeg...

  8. Drug

    OTI-030

    go.drugbank.com/drugs/DB05648
    Investigational

  9. Drug

    Iodofiltic acid I-123

    go.drugbank.com/drugs/DB05683
    Investigational

  10. Drug

    R-1487

    go.drugbank.com/drugs/DB06518
    Experimental